Home/Filings/4/0001549595-24-000140
4//SEC Filing

Kapur Anil 4

Accession 0001549595-24-000140

CIK 0001549595other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:48 PM ET

Size

5.5 KB

Accession

0001549595-24-000140

Insider Transaction Report

Form 4
Period: 2024-10-15
Kapur Anil
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2024-10-15+50,00050,000 total
    Exercise: $24.87Exp: 2034-10-14Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 1/36 of the total shares monthly beginning November 15, 2024, until the option is fully vested on October 15, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

Entity typeother

Related Parties

1
  • filerCIK 0001730703

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:48 PM ET
Size
5.5 KB